Pages that link to "Q50597328"
Jump to navigation
Jump to search
The following pages link to Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly (Q50597328):
Displaying 50 items.
- Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement (Q28175558) (← links)
- Current state of therapy for pain and inflammation (Q28191916) (← links)
- Balancing the gastrointestinal benefits and risks of nonselective NSAIDs (Q28191932) (← links)
- Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study (Q28194919) (← links)
- NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies (Q28196574) (← links)
- Epidemiology of gastroduodenal complications associated with nonsteroidal anti-inflammatory drug use (Q28212868) (← links)
- Drug-induced side effects affecting the gastrointestinal tract (Q28219073) (← links)
- Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies (Q28221704) (← links)
- The David Y. Graham lecture: use of nonsteroidal antiinflammatory drugs in a COX-2 restricted environment (Q28222253) (← links)
- The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events (Q28367917) (← links)
- A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients (Q33367787) (← links)
- Digestive symptoms in older adults: prevalence and associations with institutionalization and mortality (Q33456689) (← links)
- Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users. (Q33692833) (← links)
- Dyspepsia and heartburn (Q33722910) (← links)
- Review article: nonsteroidal anti-inflammatory drug-associated gastrointestinal complications--guidelines for prevention and treatment (Q33762461) (← links)
- Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management (Q33876258) (← links)
- Mast Cells Are Critical for Protection against Peptic Ulcers Induced by the NSAID Piroxicam (Q33999952) (← links)
- Nonsteroidal anti-inflammatory drug-associated dyspepsia: the scale of the problem (Q34134268) (← links)
- The nonsteroidal anti-inflammatory drugs controversy (Q34145490) (← links)
- A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis (Q34203085) (← links)
- Helicobacter pylori infection, intake of analgesics or anti-inflammatory medication, and personal factors in relation to dyspeptic symptoms in patients of a general practitioner (Q34218866) (← links)
- Pharmacologic management of osteoarthritis-related pain in older adults. (Q34257433) (← links)
- Cox-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly (Q34311477) (← links)
- Gastrointestinal comorbidities associated with atrial fibrillation (Q34409701) (← links)
- An evidence-based approach to the gastrointestinal safety profile of COX-2-selective anti-inflammatories (Q34475711) (← links)
- Gastrointestinal toxicity associated with nonsteroidal anti-inflammatory drugs. Epidemiologic and economic issues (Q34475729) (← links)
- Optimal management of patients with non-ulcer dyspepsia: considerations for the treatment of the elderly. (Q34481240) (← links)
- Use of Aspirin or Nonsteroidal Anti-inflammatory Drugs Increases Risk for Diverticulitis and Diverticular Bleeding (Q34851812) (← links)
- Gastrointestinal effects of NSAIDs and coxibs (Q35072859) (← links)
- Medication-induced oesophageal disorders (Q35208416) (← links)
- Quality of Co-Prescribing NSAID and Gastroprotective Medications for Elders in The Netherlands and Its Association with the Electronic Medical Record (Q35674170) (← links)
- NSAIDs and gastrointestinal complications: new clinical challenges (Q36326243) (← links)
- Chronic musculoskeletal conditions and comorbidities in primary care settings (Q36540840) (← links)
- Pharmacologic Management of Osteoarthritis-Related Pain in Older Adults: A Review Shows that Many Drug Therapies Provide Small-to-Modest Pain Relief (Q37025257) (← links)
- Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib (Q37175779) (← links)
- Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults (Q37703574) (← links)
- Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients (Q38471578) (← links)
- NSAIDs and the elderly. Toxicity and economic implications (Q41375159) (← links)
- The risks and costs of upper gastrointestinal disease attributable to NSAIDs (Q41537400) (← links)
- Does Helicobacter pylori status affect nonsteroidal anti-inflammatory drug-associated gastroduodenal pathology? (Q41757698) (← links)
- Primary prevention studies and the healthy elderly: evaluating barriers to recruitment (Q43481170) (← links)
- An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada (Q43560804) (← links)
- H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? (Q43691249) (← links)
- NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary care (Q44905463) (← links)
- GI effects of OTC analgesics: implications for product selection. (Q45099641) (← links)
- Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users (Q46742246) (← links)
- Time course and pattern of blood loss with ibuprofen treatment in healthy subjects (Q46791645) (← links)
- Prescription audit of NSAIDs and gastroprotective strategy in elderly in primary care (Q48666627) (← links)
- Gender differences in the symptoms and physical and mental well-being of dyspeptics: a population based study (Q51956019) (← links)
- Factors associated with consulting medical or non-medical practitioners for dyspepsia: an australian population-based study. (Q51971349) (← links)